RIDAURA Rx

Select the drug indication to add to your list

RIDAURA

Arthritis/rheumatic disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Auranofin 3mg; caps.

Select therapeutic use:

Indications for RIDAURA:

Active rheumatoid arthritis unresponsive to NSAIDs.

Adult:

Initially 6mg daily in 1–2 divided doses. If response inadequate after 6 months, may increase to 3mg 3 times daily. If still ineffective after 3 months, discontinue.

Children:

Not recommended.

Contraindications:

History of gold-induced disorders.

Warnings/Precautions:

Be fully familiar with chrysotherapy and this product's toxicity before use. Impaired renal or hepatic function. Inflammatory bowel disease. Rash. History of bone marrow depression. Monitor urine, blood, renal, liver function and for GI bleeding. Discontinue immediately if thrombocytopenia, proteinuria, or hematuria occurs. Pregnancy (Cat.C), nursing mothers: not recommended.

Pharmacological Class:

DMARD (gold salt).

Adverse Reactions:

Bone marrow depression, proteinuria, hematuria, diarrhea, GI upset, ulcerative colitis, rash, pruritus, exfoliative dermatitis, stomatitis, conjunctivitis, proteinuria, nephrotic syndrome, cholestatic jaundice, gold bronchitis, pneumonitis, peripheral neuropathy.

How Supplied:

Caps—60

RIDAURA 3mg capsules (Qty:60)

appx. price $1375.00